Lipoprotein-associated phospholipase A2 (Lp-PLA2) is produced by inflammatory cells. It circulates primarily bound to low-density lipoprotein (LDL) and is to a lesser extent associated with high-density lipoprotein (HDL) in human plasma.
LDL oxidation is an early key event in the pathogenesis of atherosclerosis. Elevated Lp-PLA2 levels have been found in atherosclerotic plaques and rupture lesions.
The PLAQPRO Lp-PLA2 Assay, from Enzo Life Sciences, measures the enzyme activity of Lp-PLA2 in serum samples. The assay is designed to run on automated clinical chemistry analysers, and is a convenient tool for cardiovascular studies.
The product has a wide analytical measurement range from 0–400 nmol/min/mL and an analytical sensitivity of 0.236 nmol/min/mL. It offers high specificity and reproducibility, lot after lot.
The assay comes with ready-to-use calibration standards and QC controls. It is designed to run on automated clinical chemistry analysers.
Phone: 02 9698 2022
Dojindo Laboratories ExoIsolator Exosome Isolation Kit
The ExoIsolator Exosome Isolation Kit, from Dojindo Laboratories, can collect exosomes...
Beckman Coulter Life Sciences Basophil Activation Test (BAT) for food allergy research
Beckman Coulter Life Sciences introduces its next-generation Basophil Activation Test (BAT) to...
TopoGEN Topoisomerase Assay Kits
TopoGEN provides innovative reagents and kits for topoisomerase research and mechanism-based drug...